Deborah A. Theodore, MD1; Angela R. Branche, MD2; Lily Zhang, PhD3; et alDaniel S. Graciaa, MD4; Madhu Choudhary, MD5; Timothy J. Hatlen, MD6; Raadhiya Osman, PhD7; Tara M. Babu, MD8; Samuel T. Robinson, PhD3; Peter B. Gilbert, PhD3,9; Dean Follmann, PhD10; Holly Janes, PhD3,9; James G. Kublin, MD3; Lindsey R. Baden, MD11; Paul Goepfert, MD12; Glenda E. Gray, MBBCh13,14; Beatriz Grinsztejn, MD, PhD15; Karen L. Kotloff, MD16,17; Cynthia L. Gay, MD18; Brett Leav, MD19; Jacqueline Miller, MD19; Ian Hirsch, PhD20; Jerald Sadoff, MD21; Lisa M. Dunkle, MD22; Kathleen M. Neuzil, MD17; Lawrence Corey, MD3,23; Ann R. Falsey, MD2; Hana M. El Sahly, MD24,25; Magdalena E. Sobieszczyk, MD1; Yunda Huang, PhD3,26; for the COVID-19 Prevention Network (CoVPN) JAMA Netw Open. 2023;6(7):e2323349. doi:10.1001/jamanetworkopen.2023.23349 Key Points Question What clinical and demographic factors are associated with rates of COVID-19, severe COVID-19, and SARS-CoV-2 infection? Findings In this secondary analysis of […]